Goldman Sachs’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35,000
Closed -$474K 6108
2025
Q1
$474K Sell
35,000
-54,000
-61% -$897K ﹤0.01% 5225
2024
Q4
$1.5M Buy
+89,000
New +$1.73M ﹤0.01% 4529
2018
Q2
Sell
-300
Closed -$15K 5678
2018
Q1
$15K Sell
300
-9,800
-97% -$490K ﹤0.01% 5702
2017
Q4
$506K Sell
10,100
-34,300
-77% -$1.8M ﹤0.01% 4823
2017
Q3
$2.25M Buy
44,400
+23,900
+117% +$1.13M ﹤0.01% 3878
2017
Q2
$777K Buy
20,500
+12,400
+153% +$489K ﹤0.01% 4699
2017
Q1
$312K Sell
8,100
-6,500
-45% -$196K ﹤0.01% 5436
2016
Q4
$323K Buy
14,600
+1,000
+7% +$20.5K ﹤0.01% 5427
2016
Q3
$218K Buy
13,600
+6,000
+79% +$68.5K ﹤0.01% 5757
2016
Q2
$63K Sell
7,600
-20,100
-73% -$179K ﹤0.01% 6331
2016
Q1
$194K Sell
27,700
-63,260
-70% -$318K ﹤0.01% 5653
2015
Q4
$488K Sell
90,960
-13,880
-13% -$88.7K ﹤0.01% 4941
2015
Q3
$678K Buy
+104,840
New +$1.1M ﹤0.01% 4848

Other funds holding CC

Goldman Sachs's CC Position: Q1 2026 in Review

Goldman Sachs reduced its Chemours (CC) stake by 19% in Q1 2026, selling an estimated $12M and leaving 3,014,114 shares worth $66.4M. The position accounts for 0.01% of the portfolio, ranked #1350.

Goldman Sachs first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $94M in Q3 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Goldman Sachs held 3,014,114 shares of Chemours worth $66.4M as of Q1 2026.
  • Goldman Sachs sold 687,180 Chemours shares in Q1 2026, an estimated $12M.
  • Chemours made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1350 holding.
  • Goldman Sachs first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • Goldman Sachs's Chemours position peaked at $94M in Q3 2017.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.